Cart
sales@molnova.com
Sarafloxacin hydrochloride
CAS No. 91296-87-6
Sarafloxacin hydrochloride( Sarafloxacin HCl | Sarafloxacin Hydrochloride | A-56620 )
Catalog No. M16556 CAS No. 91296-87-6
Sarafloxacin hydrochloride is a hydrochloride salt form of sarafloxacin which is a quinolone antibiotic drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 33 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSarafloxacin hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSarafloxacin hydrochloride is a hydrochloride salt form of sarafloxacin which is a quinolone antibiotic drug.
-
DescriptionSarafloxacin hydrochloride is a hydrochloride salt form of sarafloxacin which is a quinolone antibiotic drug.
-
In Vitro——
-
In Vivo——
-
SynonymsSarafloxacin HCl | Sarafloxacin Hydrochloride | A-56620
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number91296-87-6
-
Formula Weight421.83
-
Molecular FormulaC20H18ClF2N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 1 mg/mL (2.37 mM)
-
SMILESO=C(C1=CN(C2=CC=C(F)C=C2)C3=C(C=C(F)C(N4CCNCC4)=C3)C1=O)O.[H]Cl
-
Chemical Name6-Fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cao Z, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt B:601-6.
molnova catalog
related products
-
BAM-12P
BAM-12P, an endogenous opioid peptide, is a novel pro-Met-enkephalin. BAM-12P can activate human κ-opioid receptor (hKOR) with an EC50 of 101 nM and a pEC50 of 6.99. BAM-12P is a ligand for CXCR7 with an EC50 of 175 nM.
-
Nuclear Export Signa...
Nuclear Export Signal, NES, PKI
-
(S/R)-Orteronel
TAK-700 (Orteronel) is a potent and highly selective human 17, 20-lyase inhibitor with IC50 of 38 nM, exhibits >1000-fold selectivity over other CYPs (e.g. 11-hydroxylase and CYP3A4). Phase 3.
